Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome (Q34510359)

2 August 2017

Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome (English)

1 reference

2 August 2017

1 reference

11

Lee H Harrison

1 reference

2 August 2017

12

Scott K Fridkin

1 reference

2 August 2017

3

Rana A Hajjeh

1 reference

2 August 2017

Beth A Arthington-Skaggs

2

object named as

Beth A Arthington-Skaggs

1 reference

2 August 2017

13

David W Warnock

1 reference

2 August 2017

9

Brian D Plikaytis

1 reference

2 August 2017

10

Andre N Sofair

1 reference

2 August 2017

4

Naureen Iqbal

1 reference

2 August 2017

Benjamin J Park

1

1 reference

2 August 2017

Meral A Ciblak

5

1 reference

2 August 2017

Wendy Lee-Yang

6

1 reference

2 August 2017

Mario D Hairston

7

1 reference

2 August 2017

Maureen Phelan

8

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

Antimicrobial Agents and Chemotherapy

2 August 2017

1 reference

2 August 2017

50

1 reference

2 August 2017

1287-1292

1 reference

2 August 2017

4

1 reference

Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426914

Has antifungal susceptibility testing come of age?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426914

Improved detection of amphotericin B-resistant isolates of Candida lusitaniae by Etest

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426914

Candida dubliniensis fungemia: the first four cases in North America

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426914

Correlation between in vitro susceptibility determined by E test and response to therapy with amphotericin B: results from a multicenter prospective study of candidemia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426914

Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426914

Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426914

Lot-to-lot variability of antibiotic medium 3 used for testing susceptibility of Candida isolates to amphotericin B.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426914

Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426914

Detection of amphotericin B-resistant Candida isolates in a broth-based system

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426914

Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426914

Disseminated Candidiasis Due to Amphotericin B-Resistant Candida albicans

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426914

Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426914

Comparison of Etest and a tablet diffusion test with the NCCLS broth microdilution method for fluconazole and amphotericin B susceptibility testing of Candida isolates.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1426914

Emergence of resistance to amphotericin B during therapy for Candida glabrata infection in an immunocompetent host

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16569842

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16569842

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.50.4.1287-1292.2006

1 reference

2 August 2017

1 reference

2 August 2017

1 reference